-
Mashup Score: 4NAM Leadership Consortium AICC Commentary Paper: Public Comment - 10 day(s) ago
NAM Leadership Consortium AICC Commentary Paper: Public Comment.
Source: survey.alchemer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers - 10 day(s) ago
Background: Germline genetic testing is a vital component of guideline-recommended cancer care for males with pancreatic, breast, or metastatic prostate cancers. We sought to determine whether there were racial disparities in germline genetic testing completion in this population. Patients and Methods: This retrospective cohort study included non-Hispanic White and Black males with incident pancreatic, breast, or metastatic prostate cancers between January 1, 2019, and September 30, 2021. Two nationwide cohorts were examined: (1) commercially insured individuals in an administrative claims database, and (2) Veterans receiving care in the Veterans Health Administration. One-year germline genetic testing rates were estimated by using Kaplan-Meier methods. Cox proportional hazards regression was used to test the association between race and genetic testing completion. Causal mediation analyses were performed to investigate whether socioeconomic variables contributed to associations betwee
Source: jnccn.orgCategories: General Medicine News, Hem/OncsTweet-
New @JNCCN by Jeff Shevach @DukeGUCancer, @KMaxwellLab & me @Penn: Disparities in precision #oncology arise from disparities in access. We find Black-White disparities in germline testing for men with commercial insurance, NOT equal-access @DeptVetAffairs https://t.co/xyr1NQzoM7 https://t.co/JUinMFC9ZK
-
-
Mashup Score: 6Let's Talk Longevity...with Three World-Class Experts - 26 day(s) ago
The latest on living longer, aging smarter and the promise & pitfalls of predictive “pinpoint medicine”
Source: www.eventbrite.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Clinician Perspectives on Virtual Specialty Palliative Care for Patients With Advanced Illnesses | Journal of Palliative Medicine - 3 month(s) ago
Background: Patients with serious illnesses have unmet symptom and psychosocial needs. Specialty palliative care could address many of these needs; however, access varies by geography and health system. Virtual visits and automated referrals could increase access and lead to improved quality of life, health outcomes, and patient-centered care for patients with serious illness. Objectives: We sought to understand referring clinician perspectives on barriers and facilitators to utilizing virtual tools to increase upstream access to palliative care. Design: Participants in this multisite qualitative study included practicing clinicians who commonly place palliative care referrals across multiple specialties, including hematology/oncology, family medicine, cardiology, and geriatrics. All interviews were transcribed and subsequently coded and analyzed by trained research coordinators using Atlas.ti software. Settings/Subjects: This study included 23 clinicians (21 physicians, 2 nonphysician
Source: www.liebertpub.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases - 5 month(s) ago
Prostate Cancer and Prostatic Diseases – Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
New @pcan_journal: Varied estimates of HRR mutation prevalence in #prostatecancer. We analyze 3757 pts in 2 diverse real-world databases. 25% (!) germline + somatic HRRm prevalence in @flatironhealth @foundationmed CGDB, 11% somatic in @AACR Genie. #pcsm https://t.co/kVGiDhtnWZ https://t.co/a2UbQRzUfI
-
-
Mashup Score: 1
Patients receiving PROStep reported high understanding of symptoms and functional status from their oncology team, although this did not differ from controls.
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Home | Haclab - 7 month(s) ago
AI mimics human intelligence to support healthcare workers through improving diagnosis and… Read more While healthcare algorithms can improve prediction and diagnosis, they often “bake in” bia… Read more While most healthcare data comes from claims and electronic health record “exhaust”, incre… Read m ore Real-world data is data that is generated through routine health operations, often in the … Read more Cancer care is in the midst of a revolution in digital health innovations, payment reform,…
Source: haclab.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Human Algorithm Collaboration Lab | LinkedIn - 7 month(s) ago
Human Algorithm Collaboration Lab | 27 followers on LinkedIn. We research the development, validation, implementation, and scaling of algorithms in clinical care and health policy. | Founded at the Perelman School of Medicine and the Abramson Cancer Center at the University of Pennsylvania, we are a laboratory focusing on the development, validation, implementation, and scaling of advanced algorithms in clinical care and health policy.
Source: www.linkedin.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Nature – The FDA’s accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be…
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
Nature – The FDA’s accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be…
Source: www.nature.comCategories: Latest Headlines, Oncologists1Tweet
Check out @theNAMedicine fantastic #AI Code of Conduct draft document led by many close friends and mentors. Please submit comment for public comment by May 1st! https://t.co/FlPna9ioRy https://t.co/WC7IWotGdy https://t.co/AsIJaLJ0vE